OncoMatch/Clinical Trials/NCT03582124
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Is NCT03582124 recruiting? Yes, currently enrolling (Jun 2026). This Phase 1/2 trial studies Panitumumab-IRDye800 for lung carcinoma.
Treatment: Panitumumab-IRDye800 — This phase I/II trial studies the best dose and timing of panitumumab-IRDye800 in detecting cancer in participants with lung cancer during the surgery. Panitumumab-IRDye800 is a combination of the antibody drug panitumumab and IRDye800CW, an investigational dye that can be seen using a special camera. Panitumumab-IRDye800 may attach to tumor cells and make them more visible during surgery in patients with lung cancer.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Non-Small Cell Lung Carcinoma
Tumor Agnostic
Disease stage
Required: Stage IV, IVA, IVB (AJCC v8)
Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8
Performance status
KARNOFSKY/ECOG/ZUBROD 0–2
Karnofsky performance status of at least 70% or Eastern Cooperative Oncology Group (ECOG)/Zubrod level 0-2
Demographics
Prior therapy
Cannot have received: investigational drug
Lab requirements
Blood counts
hemoglobin ≥ 9 gm/dl; white blood cell count > 3000/mm^3; platelet count ≥ 100,000/mm^3
Kidney function
serum creatinine ≤ 1.5 times upper reference range
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Stanford University, School of Medicine · Palo Alto, California
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT03582124 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior investigational drug disqualifies patients from enrollment.
What disease stage is eligible?
Stage IV or IVA or IVB is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages